CFD
SANA icon

Creative Financial Designs’s Sana Biotechnology SANA Stock Holding History

Creative Financial Designs’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288 Hold
100
– – ﹤0.01% 2063
2025
Q4 		$407 Buy
+100
New +$448 ﹤0.01% 1929

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Creative Financial Designs's SANA Position: Q1 2026 in Review

Creative Financial Designs held its Sana Biotechnology (SANA) position steady in Q1 2026 at 100 shares worth $288. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Creative Financial Designs first reported a position in SANA in Q4 2025 and has held it in 2 quarters since. The position peaked at $407 in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Creative Financial Designs held 100 shares of Sana Biotechnology worth $288 as of Q1 2026.
  • Creative Financial Designs left its Sana Biotechnology share count unchanged in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #2063 holding.
  • Creative Financial Designs first reported a position in Sana Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • Creative Financial Designs's Sana Biotechnology position peaked at $407 in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.